Clinical Trial Update: A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013) [Phase 1]

View source ↗

Summary

Phase 1 trial assessing oral and IV tedizolid phosphate in hospitalized children aged 2 to <12 with confirmed or suspected gram-positive bacterial infections; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-positive Bacterial Infections

Drugs mentioned

• Tedizolid Phosphate (tedizolid phosphate)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Gram-Positive Bacterial Infections | Phase 1 | Status: COMPLETED | Results posted: 2019-12-20